Clinical Trial Update: Safety and Efficacy of MK0736 & MK0916 in Patients With Hypertension (High Blood Pressure)(0736-003)(COMPLETED) [Phase 2]

View source ↗

Summary

A completed Phase 2 trial evaluated MK0736 and MK0916 in patients with hypertension. Results from the study were posted in February 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• MK0736
• MK0916

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Hypertension | Phase 2 | Status: COMPLETED | Results posted: 2014-02-14